Top Markets
#1 Nesa Nesa +816.77%
#2 Cortex Cortex +68.49%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.50%
#4 QuantixAI QuantixAI +23.90%
#5 EXOD EXOD +22.78%
#6 BSquared Network BSquared Network +19.70%
#7 Pons Pons +18.22%
#8 Instadapp Instadapp +16.92%
#9 Magma Finance Magma Finance +12.52%
#10 OpenEden OpenEden +11.84%
Coin of the day
Nesa Nesa
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Kedudukan dalam Saham #3529
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Harga Saham
$4.64
Modal Pasaran
$5.18B
Perubahan (1 hari)
0.41%
Perubahan (1 tahun)
-37.42%
Negara
CN
Perdagangan Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Kategori

Healthcare
Sejarah pecahan saham untuk Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Saham Shenzhen Salubris Pharmaceuticals Co., Ltd. (simbol: 002294) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 26, 2026.
Satu saham 002294 yang dibeli sebelum Aug 26, 2026 kini bersamaan dengan 0 saham 002294.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 3 x4
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 3 x20
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 0 -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 6 x20
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 0 -
CH